| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
55,620,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Design Therapeutics is a preclinical-stage biopharmaceutical company pioneering GeneTAC™ molecules, which are a class of small-molecule gene targeted chimera therapeutic candidates that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. Co.'s product candidate is in Friedreich ataxia, its second GeneTAC program is in myotonic dystrophy type-1, and it is also advancing its GeneTAC portfolio to address other serious nucleotide repeat-driven monogenic diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
28,265 |
28,265 |
2,296,265 |
4,118,715 |
| Total Buy Value |
$104,605 |
$104,605 |
$5,555,212 |
$20,885,298 |
| Total People Bought |
2 |
2 |
5 |
8 |
| Total Buy Transactions |
3 |
3 |
7 |
16 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Schmid John P. |
|
– • – |
2024-03-25 |
4 |
B |
$3.74 |
$66,606 |
I/I |
17,809 |
26,965 |
0.01 |
- |
|
| Behanna Heather |
|
– • – |
2024-03-25 |
4 |
B |
$3.74 |
$4,866 |
D/D |
1,300 |
1,300 |
0.01 |
- |
|
| Schmid John P. |
|
– • – |
2024-03-22 |
4 |
B |
$3.62 |
$33,133 |
I/I |
9,156 |
9,156 |
0.01 |
- |
|
| Kim Jae B. |
Chief Medical Officer |
• – – |
2024-03-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,756 |
|
- |
|
| Lappe Rodney W |
Director |
– • – |
2023-09-29 |
4 |
B |
$2.35 |
$49,287 |
D/D |
21,000 |
133,024 |
2.39 |
- |
|
| William Arsani |
Director |
– • – |
2023-08-29 |
4 |
B |
$2.44 |
$4,782,400 |
I/I |
1,960,000 |
3,000,000 |
2.1 |
- |
|
| Prasad Deepa |
Director |
– • – |
2023-08-29 |
4 |
B |
$2.31 |
$27,670 |
D/D |
12,000 |
23,806 |
2.39 |
- |
|
| William Arsani |
Director |
– • – |
2023-08-28 |
4 |
B |
$2.15 |
$591,250 |
I/I |
275,000 |
1,040,000 |
2.1 |
- |
|
| Siffert Joao Md |
President and CEO |
• • – |
2022-12-20 |
4 |
B |
$8.38 |
$52,763 |
D/D |
6,300 |
132,619 |
2.81 |
- |
|
| George Simeon |
Director |
– • • |
2022-12-20 |
4 |
B |
$8.14 |
$325,432 |
I/I |
40,000 |
6,526,476 |
2.25 |
- |
|
| Sr One Capital Management, Llc |
10% Owner |
– – • |
2022-12-20 |
4 |
B |
$8.14 |
$325,432 |
D/D |
40,000 |
6,526,476 |
2.45 |
- |
|
| Siffert Joao Md |
President and CEO |
• • – |
2022-12-19 |
4 |
B |
$8.47 |
$9,741 |
D/D |
1,150 |
126,319 |
2.81 |
- |
|
| George Simeon |
Director |
– • • |
2022-12-19 |
4 |
B |
$8.63 |
$3,108,096 |
I/I |
360,000 |
6,486,476 |
2.25 |
- |
|
| Sr One Capital Management, Llc |
10% Owner |
– – • |
2022-12-19 |
4 |
B |
$8.63 |
$3,108,096 |
D/D |
360,000 |
6,486,476 |
2.45 |
- |
|
| George Simeon |
Director |
– • • |
2022-12-16 |
4 |
B |
$8.28 |
$4,140,550 |
I/I |
500,000 |
6,126,476 |
2.25 |
- |
|
| Sr One Capital Management, Llc |
10% Owner |
– – • |
2022-12-16 |
4 |
B |
$8.28 |
$4,140,550 |
D/D |
500,000 |
6,126,476 |
2.45 |
- |
|
| Lappe Rodney W |
Director |
– • – |
2022-12-09 |
4 |
B |
$7.96 |
$119,426 |
D/D |
15,000 |
112,024 |
2.39 |
- |
|
| Xu Stella |
Director |
– • – |
2022-03-22 |
4 |
S |
$18.63 |
$27,105 |
I/I |
(1,455) |
4,129,950 |
|
- |
|
| William Arsani |
Director |
– • – |
2022-03-21 |
4 |
B |
$18.99 |
$474,680 |
I/I |
25,000 |
2,797,501 |
2.1 |
- |
|
| Xu Stella |
Director |
– • – |
2022-03-21 |
4 |
S |
$19.01 |
$456,240 |
I/I |
(24,000) |
4,131,405 |
|
- |
|
| Xu Stella |
Director |
– • – |
2022-03-18 |
4 |
S |
$19.04 |
$10,782,852 |
I/I |
(565,425) |
4,155,405 |
|
- |
|
| Prasad Deepa |
Director |
– • – |
2022-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
11,806 |
11,806 |
|
- |
|
| William Arsani |
Director |
– • – |
2021-08-31 |
4 |
B |
$15.45 |
$618,000 |
I/I |
40,000 |
2,772,501 |
2.1 |
- |
|
| Giangiulio Dawn |
Principal Accounting OfficerOf |
• – – |
2021-08-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,500 |
|
- |
|
| William Arsani |
Director |
– • – |
2021-03-30 |
4/A |
B |
$20.00 |
$14,000,000 |
I/I |
700,000 |
700,000 |
2.1 |
- |
|
49 Records found
|
|
Page 1 of 2 |
|
|
